ABL Bio Inc (298380) — Cash Flow Reinvestment Rate
ABL Bio Inc (298380) has a Cash Flow Reinvestment Rate of 0.04x as of March 2026, reinvesting ₩1.29 Billion (capex ₩243.74 Million plus investments ₩1.04 Billion) from operating cash flow of ₩32.84 Billion. See 298380 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ABL Bio Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for ABL Bio Inc across 1 annual periods. For the full cash flow conversion analysis, see 298380 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for ABL Bio Inc (2022–2022)
Year-by-year capital reinvestment analysis for ABL Bio Inc. See ABL Bio Inc (298380) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.67x | ₩48.29 Billion | ₩72.13 Billion | ₩2.06 Billion | — |